A Mayo Clinic study aims to find out whether doctors can use wearable sensors and prescription-only iPads to convince COPD patients to do pulmonary rehab.

Now a study at the Mayo Clinic aims to find out whether doctors can use prescription-only iPads and wearable sensors to convince more people with COPD to do the pulmonary rehab that is proved to keep them more healthy. The technology teaches patients to do their low-impact rehab at home, because history shows 70 percent of them will fail to come to a clinic for it.

The independently funded clinical study is designed to generate objective data about the effectiveness of health care software made by Novu of St. Louis Park and wearable sensors from St. Paul’s Minnesota HealthSolutions Corp. The study, doctors say, is also a glimpse into the future for the burgeoning field of mobile health (mHealth) applications.

“The technology is advancing pretty fast. So it comes down to how fast people can demonstrate evidence of predictability and accuracy and making sure that it’s safe and that we actually can achieve better results with it,” said HealthPartners vice president Dr. Kevin Ronneberg, who’s not involved in the Mayo study.

View the full story at www.startribune.com